Related Experiment Video
Updated: Oct 7, 2025
10:12
Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
Published on: September 11, 2019
8.8K
Inducing Long-Term HIV-1 Latency in the TKO-BLT Mouse Model
1Department of Biochemistry, Microbiology and Immunology, College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada.
Methods in Molecular Biology (Clifton, N.J.)
|January 5, 2022
Summary
This study details methods for inducing HIV-1 latency in TKO-BLT humanized mice. This model aids research into HIV-1 cure strategies by mimicking the human immune system response.
Area of Science:
- Immunology
- Virology
- Preclinical Research
Background:
- Humanized mouse models are crucial for studying HIV-1 infection and treatment.
- Bone marrow, liver, thymus (BLT) humanized mice offer reconstituted human immune systems for HIV-1 cure research.
- The TKO-BLT model enhances long-term study viability by resisting wasting syndrome and graft-versus-host disease (GVHD).
Purpose of the Study:
- To describe methods for inducing HIV-1 latency in TKO-BLT humanized mice.
- To establish a model for evaluating novel HIV-1 cure interventions.
- To facilitate long-term studies on HIV-1 persistence and eradication.
Main Methods:
- Utilizing the TKO-BLT humanized mouse model.
- Inducing latent human immunodeficiency virus type 1 (HIV-1) infection.
- Administering combination antiretroviral therapy (cART) via injectable and free-fed regimens.
Main Results:
- Successful induction of HIV-1 latency in TKO-BLT mice was achieved.
- The TKO-BLT model demonstrated resistance to GVHD and wasting syndrome, enabling long-term studies.
- The described methods provide a platform for testing HIV-1 cure strategies.
Conclusions:
- The TKO-BLT humanized mouse model is a robust platform for studying HIV-1 latency.
- The methods for inducing latency support the evaluation of immune-based HIV-1 cure interventions.
- This model advances research toward an effective cure for HIV-1.
